Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 20 de 24.326
Filtrar
Mais filtros

Filtros aplicados
Intervalo de ano de publicação
1.
Bioresour Technol ; 391(Pt B): 130005, 2024 Jan.
Artigo em Inglês | MEDLINE | ID: mdl-37952588

RESUMO

Microbial refactoring offers sustainable production of plant-sourced pharmaceuticals associated with high production costs, ecological harms, and supply chain dependencies. Here, microbial tabersonine production in Saccharomyces cerevisiae is modeled during early-stage development (TRL: 3-5), guiding decisions for process-scale economic and environmental optimization. The base-case 0.7 mg/L titer indicated a minimum selling price (MSP) of $3,910,000/kg and global warming potential (GWP) of 2,540 kgCO2eq/g. The industrial process at 1 g/L resulted in an MSP of 4,262 $/kg and a GWP of 6.36 kgCO2eq/g. Location analysis indicated a sustainability trade-off between France, USA, Poland, and China, with the written order of declining MSP and increasing GWP. Continuous processing promised reducing the MSP by 18-27 %, and the GWP by 17-31 %. In-situ product extraction during fermentation was estimated to lower the MSP by 41-61 %, and the GWP by 30-75 %. In addition to showcasing a combined TEA-LCA on biopharmaceuticals, the early-stage assessment approach guides bioprocess optimization.


Assuntos
Alcaloides de Triptamina e Secologanina , Fermentação , Custos e Análise de Custo , Meio Ambiente , China
2.
Sci Total Environ ; 906: 167598, 2024 Jan 01.
Artigo em Inglês | MEDLINE | ID: mdl-37802362

RESUMO

Pulp and paper wastewater (P&P WW) often requires tertiary treatment to remove refractory compounds not eliminated by conventional biological treatment, ensuring compliance with high-quality effluent discharge or reuse standards. This study employs a life cycle assessment (LCA) methodology to compare alternative tertiary treatment technologies for P&P WW and rank them accordingly. The evaluated technologies in the scenarios include inorganic (S1) and organic (S2) coagulation-flocculation, ozonation (O3) (S3), O3+granular activated carbon (GAC) (S4), and ultrafiltration (UF)+reverse osmosis (RO) (S5). The analysis focuses on a P&P wastewater treatment plant (WWTP) in Northeastern Italy. The LCA is complemented by an economic analysis considering each technology's capital and operating costs, as well as potential revenues from internal effluent reuse. Results indicate that S4 (O3+GAC) outranks all the other scenarios in terms of both environmental performance and economic viability, primarily due to the advantages associated with effluent reuse. S5 (UF+RO), which also involves reuse, is limited by the high energy consumption of UF+RO, resulting in increased environmental impacts and costs. The physicochemical scenario S2 (Chem Or), currently utilized in the WWTP under study, remains the best-performing technology in the absence of effluent reuse. In contrast, S3 (O3 alone) exhibits the poorest environmental and economic outcomes due to substantial energy requirements for O3 generation and the inability to reuse the treated effluent directly. Lastly, a sensitivity analysis underscores the strong influence of chemical dosages in S1 and S2 on environmental and economic impacts, which is more significant than the impact of water reuse percentages in S4 and S5. The high electricity cost observed during 2022 negatively affects the energy-intensive scenarios (S3-S5), making coagulation-flocculation (S1-S2) even more convenient.

3.
Sci Total Environ ; 907: 167794, 2024 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-37852502

RESUMO

Limestone calcined clay cement (LC3) has gained attention in the research paradigm, and useful data is available in scattered form, necessitates comprehensive review to provide global insight into important research questions, i.e., micro-macro response, and environmental implications, keeping in view the future research directions. In this regard, the current article provides a comprehensive insight into LC3, focusing on its micro-macro mechanisms and critically examining different aspects such as chemical composition, hydration chemistry with special attention on phase assemblage, impacts of various salts and carbonation, rheological properties, mechanical behavior, high-temperature exposure, and compatibility with different admixtures. Additionally, this article explores the sustainable and environmentally friendly applications of LC3, with an emphasis on its economic and environmental advantages highlighted by pertinent data and lifecycle assessments (LCA). Comprehensive data was gathered from a micro-macro perspective considering SCMs from different regional sources, and comparisons were drawn with Ordinary Portland Cement (OPC). Further, comparative economic and environmental aspects for different grades of LC3 and OPC were evaluated and analyzed considering energy demand, cost-effectiveness, and energy efficiency. The micro-macro characteristics of LC3 are found to be majorly dependent on its constituent, particularly clinker composition and alumina content in SCMs, which varies regionally. This review study outlines the critical research directions, i.e., enhancement of mechanical behavior and rheology, incorporation of super plasticizers and waste materials for resource conservation, and improvement of carbonation resistance for durability to make LC3 a sustainable and first-choice cement.

4.
Sci Total Environ ; 907: 168080, 2024 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-37898212

RESUMO

Enhanced-efficiency nitrogen fertilizer (EENF), developed to improve synchronization between crop nitrogen demand and nitrogen supply, can guarantee global food security and mitigate nitrogen fertilizer-induced environmental consequences. However, comprehensive assessments of how EENF affects CH4 and CO2 emissions from paddies and drylands and the associated benefits are lacking. Here, we present the results of a global meta-analysis conducted to assess the above issues. Our results showed that, on average, applying nitrification inhibitors and coated controlled-release urea to paddy fields significantly decreased CH4 emissions by 24.0 % and 25.3 %, respectively, likely due to the weakened inhibition of NH4+ on CH4 oxidation. A similar effect on CO2 emission was observed when farmers used nitrification inhibitors and coated controlled-release urea in the drylands. The meta-analysis results revealed that all EENF products could help mitigate the global warming potential of paddies and drylands. After incorporating the benefit of global warming potential mitigation into the cost-benefit analysis, coated controlled-release urea application in paddies and drylands produced the largest environmental gains of $ 76.34 ha-1 and $ 79.35 ha-1, respectively. However, the relatively lower purchasing cost and larger yield increase of urease inhibitors resulted in the largest net profits for farmers. Moreover, a greater economic return was generally achieved by applying EENF to paddy fields than by applying EENF to drylands. These findings highlight the role of EENF in mitigating the global warming potential of global paddy and dryland fields, which has facilitated the comprehensive recognition of EENF-induced impacts.

5.
Sci Total Environ ; 907: 168020, 2024 Jan 10.
Artigo em Inglês | MEDLINE | ID: mdl-37898217

RESUMO

The use of photovoltaic (PV) technology in agricultural production can mitigate the environmental impacts of mushroom farming. However, changes in the environmental impacts and economic benefits of the application of PV technology are still unclear. Thus, we evaluated the environmental impacts, energy flow, and economic aspects of mushroom (Panus giganteus) farming systems without solar PV (WS) technology and with PV technology from the generation of substrate materials through harvesting. In addition to a 27 % increase in terrestrial ecotoxicity, P. giganteus farming with PV technology reduced all impact categories by 4-60 %, with a 60 % reduction in CO2 emissions and a 25 % reduction in land resources. These findings highlight the importance of combining PV technology with mushroom farming in agricultural carbon reduction and the efficient use of land resources. In terms of the climate change impact, the PV system reduced CO2 emissions by 2.94 kg CO2 eq./kg of mushrooms compared with the WS system, wherein the aspects of substrate transformation, spawn running, and cultivation were reduced by 78.27-89.91 %. The cumulative exergy demand (CExD) analysis showed that P. giganteus farming combined with PV technology reduced the total CExD by 48 %. With the application of PV technology, the top contributor to the total CExD of mushroom farming shifted from electricity to transportation throughout the supply chain. The PV system reduced costs by 22.09 % and increased the total revenue by 22 % and the cost-benefit ratio by 50 %. Halving the transportation distances of substrate materials and performing localized substitution of wood chips resulted in a 3-34 % reduction in the environmental impacts category and a 23-30 % reduction in nonrenewable fossil energy consumption. These results showed that improvements helped optimize the environmental performance in terms of carbon reduction and energy mixing. Thus, combining PV technology with greenhouse mushroom farming can improve trends in energy and environmental damage.

6.
Spectrochim Acta A Mol Biomol Spectrosc ; 306: 123621, 2024 Feb 05.
Artigo em Inglês | MEDLINE | ID: mdl-37950932

RESUMO

Treating polluted wastewater effluents on a large-scale requires the development of high performance and cost-effective adsorbents. The recycling of waste mandarin peels, an environmentally friendly, and copiously available waste biomass into biochar (MRBC), has been approached. In the context of finding affordable and effective solutions for depollution of wastewater, MRBC was used for the adsorption of two dyes: methylene blue (MB) as well as basic fuchsin (BF) from their individual solutions and binary combinations. Batch adsorption studies were performed by employing the Box-Behnken (BB) design. The adsorption competency of dyes was analyzed to find the percentage removal (%R) and the adsorption capacity (qe, mg/g). The dependent parameters (qe and %R) were determined as a function of pH, dose of MRBC (AD), contact time (CT), and concentration of methylene blue [MB]/ basic fuchsin [BF]. Removal of 98.14% of MB and 83.18% of BF was successfully achieved. Equilibrium experiments depicted that Langmuir and Freundlich models suit adsorption of dyes. The maximum adsorption capacity (qmax) was 99.11 (MB) and 78.01 mg/g (BF), individually. However, when the dyes are combined, the qmax decreased to 57.09 and 68.52 mg/g for MB and BF, correspondingly. The cost of MRBC was estimated to be âˆ¼ 4 USD/kg, while the overall cost of wastewater treatment was estimated to be 1.06 USD/m3/year.


Assuntos
Águas Residuárias , Poluentes Químicos da Água , Corantes , Azul de Metileno , Análise Custo-Benefício , Adsorção , Cinética , Concentração de Íons de Hidrogênio
7.
Indian J Crit Care Med ; 27(10): 759-765, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37908427

RESUMO

Purpose: To evaluate the clinical effectiveness and health economic benefits of a novel indwelling lattice-based device for fecal management in bedridden patients. Materials and methods: This nonrandomized, two-arm study included 70 bedridden patients (≥18 years exhibiting liquid stool) referred from the ICU of surgery and medicine units of a 2000-bed tertiary care referral hospital, assigned to the intervention and control groups. About 35 patients were eligible to be included in the intervention group while 35 patients with contraindications to the intervention device were included in the usual care control group. Assessments were made before and every 24 hours during the study, and all patients were closely monitored for development of incontinence-associated dermatitis (IAD) and hospital-acquired pressure injury. Results: The test device was successfully deployed on the first attempt and effectively diverted fecal matter in all 35 patients, with no adverse events. In the control group, 83% of the patients developed IAD, which resulted in prolonged hospitalization and increased expenses. Overall, the control group (with adult diapers) required greater time, resources, and efforts for fecal management and resulted in increased patient morbidity. Conclusion: The patient management time, resource consumption, overall cost of hospital admission, and the complication rates are significantly lower with the use of the novel lattice-based device than with the use of adult diapers for fecal management. How to cite this article: Sheth H, Rao S, Karthik V. Clinical and Health Economic Evaluation of a Novel Device for Fecal Management in Bedridden Patients. Indian J Crit Care Med 2023;27(10):759-765.

8.
Artigo em Inglês | MEDLINE | ID: mdl-37950824

RESUMO

INTRODUCTION: Funding decisions for many health technologies occur without undergoing health technology assessment (HTA), in particular, without assessment of cost effectiveness (CE). Immunoglobulins in Australia are an interesting case study because they have been used for a long time for various rare disorders and their price is publicly available. Undertaking an HTA enables us to assess CE for an intervention for which there is limited clinical and economic evidence. This study presents a post-market review to assess the CE of immunoglobulins for the treatment of multifocal motor neuropathy (MMN) compared with best supportive care. METHODS: A Markov model was used to estimate costs and quality-adjusted life-years (QALYs). Input sources included randomised controlled trials, single-arm studies, the Australian clinical criteria for MMN, clinical guidelines, previous Medical Services Advisory Committee (MSAC) reports and inputs from clinical experts. Sensitivity analyses were conducted to assess the uncertainty and robustness of the CE results. RESULTS: The cost per patient of treating MMN with immunoglobulin was AU$275,853 versus AU$26,191when no treatment was provided, with accrued QALYs of 6.83 versus 6.04, respectively. The latter translated into a high incremental cost-effectiveness ratio (ICER) of AU$317,552/QALY. The ICER was most sensitive to the utility weights and the price of immunoglobulins. MSAC advised to continue funding of immunoglobulins on the grounds of efficacy, despite the high and uncertain ICER. CONCLUSIONS: Beyond the ICER framework, other factors were acknowledged, including the high clinical need in a patient population for which there are no other active treatments available. This case study highlights the challenges of conducting HTA for already funded interventions, and the efficiency trade-offs required to fund effective high-cost therapies in rare conditions.

9.
Artigo em Inglês | MEDLINE | ID: mdl-37950886

RESUMO

Antimicrobial resistance is a pandemic problem, causing substantial health and economic burdens. Antimicrobials are extensively used in livestock and aquaculture, exacerbating this global threat. Fostering the prudent use of antimicrobials will safeguard animal and human health. A lack of knowledge about alternatives to replace antimicrobials, and their effectiveness under field conditions, hampers changes in farming practices. This work aimed to understand the impact of strategies to reduce antimicrobial usage (AMU) in livestock and aquaculture, under field conditions, using a structured scoping literature review. The Extension for Scoping Reviews of the Preferred Reporting Items for Systematic Reviews and Meta-Analysis guidelines (PRISMA-ScR) were followed and the Patient, Intervention, Comparison, Outcome, Time and Setting (PICOTS) framework used. Articles were identified from CAB Abstracts, MEDLINE and Scopus. A total of 7505 unique research articles were identified, 926 of which were eligible for full-text assessment; 203 articles were included in data extraction. Given heterogeneity across articles in the way alternatives to antimicrobials or interventions against their usage were described, there was a need to standardize these by grouping them in categories. There were differences in the impacts of the strategies between and within species; this highlights the absence of a 'one-size-fits-all' solution. Nevertheless, some options seem more promising than others, as their impacts were consistently equivalent or positive when compared with animal performance using antimicrobials. This was particularly the case for bioactive protein and peptides, and feed/water management. The outcomes of this work provide data to inform cost-effectiveness assessments of strategies to reduce AMU.

11.
Cost Eff Resour Alloc ; 21(1): 82, 2023 Nov 06.
Artigo em Inglês | MEDLINE | ID: mdl-37932748

RESUMO

BACKGROUND: In recent years, numerous guidelines and expert consensus have recommended the inclusion of digital technologies and products in cardiac rehabilitation. Digital therapeutics (DTx) is an evidence-based medicine that uses digital means for data collection and monitoring of indicators to control and optimize the treatment, management, and prevention of disease. OBJECTIVE: This study collected and reviewed real-world data and built a model using health economics assessment methods to analyze the potential cost-effectiveness of DTx applied to home-based cardiac rehabilitation for patients with chronic heart failure. From the perspective of medical and health decision-makers, the economic value of DTx is evaluated prospectively to provide the basis and reference for the application decision and promotion of DTx. METHODS: Markov models were constructed to simulate the outcomes of DTx for home-based cardiac rehabilitation (DT group) compared to conventional home-based cardiac rehabilitation (CH group) in patients with chronic heart failure. The model input parameters were clinical indicators and cost data. Outcome indicators were quality-adjusted life years (QALYs) and incremental cost-effectiveness ratios (ICERs). The robustness of the evaluation methods and results was tested using sensitivity analyses. Clinical indicators, cost data, and health utility values were obtained from real-world data, including clinical study data, published literature, and public website information. RESULTS: The Markov model simulated a time span of 10 years, with a cycle set at one month, for 120 cycles. The results showed that the per capita cost of the CH group was 38,442.11 CNY/year, with a QALY of 0.7196 per person per year. The per capita cost of the DT group was 42,300.26 CNY/year, with a QALY of 0.81687 per person per year. The ICER per person was 39,663.5 CNY/QALY each year, which was below the willingness-to-pay threshold of 85,698 CNY (China's GDP per capita in 2022). CONCLUSIONS: DTx for home-based cardiac rehabilitation is an extremely cost-effective rehabilitation option compared with conventional home-based cardiac rehabilitation. DTx for home-based cardiac rehabilitation is potentially valuable from the perspective of healthcare decision-makers.

12.
Diabet Med ; : e15251, 2023 Nov 01.
Artigo em Inglês | MEDLINE | ID: mdl-37915225

RESUMO

BACKGROUND: Type 1 diabetes mellitus (T1DM) is one of the most burdensome chronic diseases in the world. Health utility values are an important tool for quantifying this disease burden and conducting cost-utility analyses. This review aimed to derive a reference set of health utility values for children and adolescents with T1DM. METHODS: We searched MEDLINE and Embase from inception to March 2023 for health utility values of T1DM children and adolescents (aged ≤18 years) measured using direct and indirect preference elicitation approaches. Utility estimates were pooled by meta-analyses with subgroup analyses to evaluate differences by populations and elicitation approaches. RESULTS: Six studies involving 1276 participants were included in this study. Meta-analysis showed the overall utility value of children and adolescents with T1DM was 0.91 (95% CI 0.89-0.93). The utility value of T1DM children and adolescents with complications was 0.90 (95% CI 0.88-0.92), which was lower than those without complications (0.96, 95% CI 0.95-0.97). The utility value of children (aged <13 years) was higher than adolescents (aged 13-18 years) (0.90 vs. 0.85). The utility value measured by the EQ-5D-3L (0.91) was higher than the HUI3 (0.89), the SF-6Dv1 (0.83), and the time trade-off (0.81). The parent proxy-reported was similar to the patient self-reported (0.91 vs. 0.91). CONCLUSIONS: This study developed a reference set of pooled utility estimates for children and adolescents with T1DM, which is helpful for understanding the overall health status of T1DM and conducting economic evaluations. Further studies are needed to explore the utilities of T1DM with different types of complications.

13.
BMC Health Serv Res ; 23(1): 1220, 2023 Nov 07.
Artigo em Inglês | MEDLINE | ID: mdl-37936221

RESUMO

BACKGROUND: Cardiac arrest is a major public health issue in Europe. Cardiac arrest seems to be associated with a large socioeconomic burden in terms of resource utilization and health care costs. The aim of this study is the analysis of the economic burden of cardiac arrest in Spain and a cost-effectiveness analysis of the key intervention identified, especially in relation to neurological outcome at discharge. METHODS: The data comes from the information provided by 115 intensive care and cardiology units from Spain, including information on the care of patients with out-of-hospital cardiac arrest who had a return of spontaneous circulation. The information reported by theses 115 units was collected by a nationwide survey conducted between March and September 2020. Along with number of patients (2631), we also collect information about the structure of the units, temperature management, and prognostication assessments. In this study we analyze the potential association of several factors with neurological outcome at discharge, and the cost associated with the different factors. The cost-effectiveness of using servo-control for temperature management is analyzed by means of a decision model, based on the results of the survey and data collected in the literature, for a one-year and a lifetime time horizon. RESULTS: A total of 109 cardiology units provided results on neurological outcome at discharge as evaluated with the cerebral performance category (CPC). The most relevant factor associated with neurological outcome at discharge was 'servo-control use', showing a 12.8% decrease in patients with unfavorable neurological outcomes (i.e., CPC3-4 vs. CPC1-2). The total cost per patient (2020 Euros) was €73,502. Only "servo-control use" was associated with an increased mean total cost per hospital. Patients treated with servo-control for temperature management gained in the short term (1 year) an average of 0.039 QALYs over those who were treated with other methods at an increased cost of €70.8, leading to an incremental cost-effectiveness ratio of 1,808 euros. For a lifetime time horizon, the use of servo-control is both more effective and less costly than the alternative. CONCLUSIONS: Our results suggest the implementation of servo-control techniques in all the units that are involved in managing the cardiac arrest patient from admission until discharge from hospital to minimize the neurological damage to patients and to reduce costs to the health and social security system.


Assuntos
Parada Cardíaca , Parada Cardíaca Extra-Hospitalar , Humanos , Espanha , Análise Custo-Benefício , Estresse Financeiro , Parada Cardíaca/terapia , Custos de Cuidados de Saúde , Parada Cardíaca Extra-Hospitalar/terapia
14.
Zhonghua Yan Ke Za Zhi ; 59(11): 919-929, 2023 Nov 11.
Artigo em Chinês | MEDLINE | ID: mdl-37936360

RESUMO

Objective: To perform a health economic evaluation of telemedicine diabetic retinopathy (DR) examination with a non-mydriatic fundus camera in China and to investigate the optimal examination interval. Methods: Based on 18 peer-reviewed articles related to epidemiology, clinical trial, and health economic evaluation of DR, surveys from 9 ophthalmologists in 3 tertiary hospitals in China, price lists for medical services in each province, and the negotiated price in 2021, a Markov model was conducted to evaluate the cost utility of telemedicine eye examination for diabetes mellitus patients aged 45 and older from the health system perspective. Separate analyses were performed for no examination and for examination intervals of every 1 to 5 years to predict the lifetime health gain, including cumulative days of blindness, cumulative life years, and quality-adjusted life years (QALYs), and costs for unilateral and bilateral direct medication with a 3.5% discount rate. Results: The cumulative days of blindness in the absence of a DR screening were 2 375.00 days, and ranged from 701.00 to 738.00 days for five different DR screening interval programs. The cumulative life years for no screening and five DR screening programs ranged from 27.120 34 to 28.005 00 years, with QALYs ranging from 9.502 96 to 9.875 02. The direct medication costs in the absence of a DR screening program were 72 785.00 yuan for both unilateral and bilateral scenarios. For the five DR screening intervals, the direct medication costs ranged from 52 065.00 to 52 408.00 yuan for unilateral and 79 100.00 to 79 603.00 yuan for bilateral. Comparing the incremental cost-effectiveness ratios between the DR screening intervals and no screening, the 1-to 5-year intervals were dominant in the unilateral scenario (between -56 368.54 and -55 523.75 yuan/QALY). In the bilateral scenario, the ratios ranged from 17 469.07 to 18 325.15 yuan/QALY. Using a willingness-to-pay threshold equal to the per capita GDP (80 976 yuan/QALY), the 1-year DR screening interval had an 85.9% probability of being cost-effective and a 55.2% probability of being dominant in the unilateral scenario. In the bilateral scenario, the 2-year interval held a 61.4% probability of being cost-effective. Conclusions: Analyses on the remote fundus consultation in diabetic patients and health economics based on the Markov model indicate that telemedicine DR examination through a non-mydriatic fundus camera can be effectively employed for diabetes mellitus patients in China. DR examination every two years is recommended for general diabetic patients, and DR examination every year may be chosen in developed areas.


Assuntos
Diabetes Mellitus , Retinopatia Diabética , Telemedicina , Humanos , Análise Custo-Benefício , Retinopatia Diabética/diagnóstico , Programas de Rastreamento , Cegueira , China
15.
Public Health Res (Southampt) ; 11(11): 1-101, 2023 Nov.
Artigo em Inglês | MEDLINE | ID: mdl-37953640

RESUMO

Background: Having a good start in life during pregnancy and infancy has been shown to be important for living both a healthy life and a longer life. Despite the introduction of many policies for the early-years age group, including voucher schemes, with the aim of improving nutrition, there is limited evidence of their impact on health. Objectives: To assess the effectiveness of the Healthy Start voucher scheme on infant, child and maternal outcomes, and to capture the lived experiences of the Healthy Start voucher scheme for low-income women. Design: This was a natural experiment study using existing data sets, linked to routinely collected health data sets, with a nested qualitative study of low-income women and an assessment of the health economics. Setting: Representative sample of Scottish children and UK children. Participants: Growing Up in Scotland cohort 2 (n = 2240), respondents to the 2015 Infant Feeding Study (n = 8067) and a sample of 40 participants in the qualitative study. Interventions: The Health Start voucher, a means-tested scheme that provides vouchers worth £3.10 per week to spend on liquid milk, formula milk, fruit and vegetables. Main outcome measures: Infant and child outcomes - breastfeeding initiation and duration; maternal outcomes - vitamin use pre and during pregnancy. Results: The exposed group were women receiving the Healthy Start voucher (R), with two control groups: eligible and not claiming the Healthy Start voucher (E) and nearly eligible. There was no difference in vitamin use during pregnancy for either comparison (receiving the Healthy Start voucher, 82%; eligible and not claiming the Healthy Start voucher, 86%; p = 0.10 vs. receiving the Healthy Start voucher, 87%; nearly eligible, 88%; p = 0.43) in the Growing Up in Scotland cohort. Proportions were similar for the Infant Feeding Study cohort (receiving the Healthy Start voucher, 89%; eligible and not claiming the Healthy Start voucher, 86%; p = 0.01 vs. receiving the Healthy Start voucher, 89%; nearly eligible, 87%; p = 0.01); although results were statistically significantly different, these were small effect sizes. There was no difference for either comparison in breastfeeding initiation or breastfeeding duration in months in Growing Up in Scotland, but there was a negative effect of the Healthy Start voucher in the Infant Feeding Survey. This contrast between data sets indicates that results are inconclusive for breastfeeding. The qualitative study found that despite the low monetary value the women valued the Healthy Start voucher scheme. However, the broader lives of low-income women are crucial to understand the constraints to offer a healthy diet. Limitations: Owing to the policy being in place, it was difficult to identify appropriate control groups using existing data sources, especially in the Infant Feeding Study. Conclusions: As the Healthy Start voucher scheme attempts to influence health behaviour, this evaluation can inform other policies aiming to change behaviour and use voucher incentives. The null effect of Healthy Start vouchers on the primary outcomes may be due to the value of the vouchers being insufficient to change the broader lives of low-income women to offer a healthy diet. Future work: The methods developed to undertake an economic evaluation alongside a natural experiment using existing data can be used to explore the cost-effectiveness of the Healthy Start voucher scheme. Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Public Health Research programme and will be published in full in Public Health Research; Vol. 11, No. 11. See the NIHR Journals Library website for further project information.


United Kingdom governments have introduced many policies to support infants and their families. Most of these policies have not been evaluated in terms of health outcomes. Therefore, there is limited evidence for policy-makers about whether or not the right policies are in place to make a difference to the health of young children and their families. We investigated the impact of the Healthy Start voucher scheme (worth £3.10 per week to spend on milk, fruit and vegetables) on the health of low-income mothers, and their infants and young children, in particular vitamin use of mothers and breastfeeding of infants. Using survey data, there were high rates of vitamin use during pregnancy, but fewer women taking vitamins before pregnancy. There was no effect of Healthy Start vouchers on taking vitamins before or during pregnancy. There was inconclusive evidence of the effect of Healthy Start vouchers on breastfeeding, indicating that use of the vouchers does not discourage breastfeeding in women with low incomes. From interviews with mothers, we found that they valued the Healthy Start vouchers and understood the aims of the policy. Healthy Start vouchers were not mentioned in decision-making around breastfeeding. Women's choice to breast or formula feed was based on a range of other factors, such as support to breastfeed. They wanted to provide a healthy diet for their families, but owing to living on low incomes did not always manage it. Policy-makers still need more evidence about the effects of voucher schemes to improve the health of low-income mothers, and their infants and young children. The decision-makers require evidence to determine where to allocate limited resources. There is a need to improve support for low-income families to provide their families with a healthy diet.


Assuntos
Aleitamento Materno , Vitaminas , Lactente , Gravidez , Humanos , Feminino , Criança , Masculino , Frutas , Verduras , Armazenamento e Recuperação da Informação
16.
Health Technol Assess ; 27(16): 1-140, 2023 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-37924278

RESUMO

Background: Cascade testing the relatives of people with familial hypercholesterolaemia is an efficient approach to identifying familial hypercholesterolaemia. The cascade-testing protocol starts with identifying an index patient with familial hypercholesterolaemia, followed by one of three approaches to contact other relatives: indirect approach, whereby index patients contact their relatives; direct approach, whereby the specialist contacts the relatives; or a combination of both direct and indirect approaches. However, it is unclear which protocol may be most effective. Objectives: The objectives were to determine the yield of cases from different cascade-testing protocols, treatment patterns, and short- and long-term outcomes for people with familial hypercholesterolaemia; to evaluate the cost-effectiveness of alternative protocols for familial hypercholesterolaemia cascade testing; and to qualitatively assess the acceptability of different cascade-testing protocols to individuals and families with familial hypercholesterolaemia, and to health-care providers. Design and methods: This study comprised systematic reviews and analysis of three data sets: PASS (PASS Software, Rijswijk, the Netherlands) hospital familial hypercholesterolaemia databases, the Clinical Practice Research Datalink (CPRD)-Hospital Episode Statistics (HES) linked primary-secondary care data set, and a specialist familial hypercholesterolaemia register. Cost-effectiveness modelling, incorporating preceding analyses, was undertaken. Acceptability was examined in interviews with patients, relatives and health-care professionals. Result: Systematic review of protocols: based on data from 4 of the 24 studies, the combined approach led to a slightly higher yield of relatives tested [40%, 95% confidence interval (CI) 37% to 42%] than the direct (33%, 95% CI 28% to 39%) or indirect approaches alone (34%, 95% CI 30% to 37%). The PASS databases identified that those contacted directly were more likely to complete cascade testing (p < 0.01); the CPRD-HES data set indicated that 70% did not achieve target treatment levels, and demonstrated increased cardiovascular disease risk among these individuals, compared with controls (hazard ratio 9.14, 95% CI 8.55 to 9.76). The specialist familial hypercholesterolaemia register confirmed excessive cardiovascular morbidity (standardised morbidity ratio 7.17, 95% CI 6.79 to 7.56). Cost-effectiveness modelling found a net health gain from diagnosis of -0.27 to 2.51 quality-adjusted life-years at the willingness-to-pay threshold of £15,000 per quality-adjusted life-year gained. The cost-effective protocols cascaded from genetically confirmed index cases by contacting first- and second-degree relatives simultaneously and directly. Interviews found a service-led direct-contact approach was more reliable, but combining direct and indirect approaches, guided by index patients and family relationships, may be more acceptable. Limitations: Systematic reviews were not used in the economic analysis, as relevant studies were lacking or of poor quality. As only a proportion of those with primary care-coded familial hypercholesterolaemia are likely to actually have familial hypercholesterolaemia, CPRD analyses are likely to underestimate the true effect. The cost-effectiveness analysis required assumptions related to the long-term cardiovascular disease risk, the effect of treatment on cholesterol and the generalisability of estimates from the data sets. Interview recruitment was limited to white English-speaking participants. Conclusions: Based on limited evidence, most cost-effective cascade-testing protocols, diagnosing most relatives, select index cases by genetic testing, with services directly contacting relatives, and contacting second-degree relatives even if first-degree relatives have not been tested. Combined approaches to contact relatives may be more suitable for some families. Future work: Establish a long-term familial hypercholesterolaemia cohort, measuring cholesterol levels, treatment and cardiovascular outcomes. Conduct a randomised study comparing different approaches to contact relatives. Study registration: This study is registered as PROSPERO CRD42018117445 and CRD42019125775. Funding: This project was funded by the National Institute for Health and Care Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 27, No. 16. See the NIHR Journals Library website for further project information.


Familial hypercholesterolaemia is an inherited condition that causes raised cholesterol levels from birth and increases risk of heart disease if left untreated. After someone in a family is found to have familial hypercholesterolaemia (called an index case), their close relatives need to be contacted and checked to see if they have familial hypercholesterolaemia, using genetic or cholesterol testing. This is called 'cascade testing'. We planned to find the most cost-effective and acceptable way to do this. The relatives could be contacted for testing by the index case (indirect approach), by a health-care professional (direct approach) or by a combination of both approaches. We found, based on looking at hospital records, that more relatives were tested if health-care professionals directly contacted relatives. In previous studies, slightly more relatives were tested for familial hypercholesterolaemia with a combination approach. Interviews with patients also suggested that the direct approach was the most effective, but the most acceptable and successful approach depends on family relationships: using one approach for some families and using both for other families. Furthermore, by looking at the health-care records of large numbers of patients, we confirmed that people with a recorded diagnosis of familial hypercholesterolaemia in general practice records have a much higher risk of heart disease than the general population, and this was especially so for those with previous heart disease and/or raised cholesterols levels when diagnosed. However, one-quarter of new patients with familial hypercholesterolaemia recorded in their records were not treated within 2 years, with less than one-third reaching recommended cholesterol levels. We used what we had learned to help us estimate the most cost-effective way to do cascade testing. This showed that if the health service directly contact all relatives simultaneously for further assessment, rather than the current approach whereby close (first-degree) relatives are contacted first, this was cost-effective and good value for money.


Assuntos
Doenças Cardiovasculares , Hiperlipoproteinemia Tipo II , Humanos , Análise de Custo-Efetividade , Análise Custo-Benefício , Hiperlipoproteinemia Tipo II/diagnóstico , Hiperlipoproteinemia Tipo II/terapia , Hiperlipoproteinemia Tipo II/genética , Colesterol
17.
Eur J Cancer Prev ; 2023 Nov 23.
Artigo em Inglês | MEDLINE | ID: mdl-37933867

RESUMO

OBJECTIVE: To assess the costs and benefits of two algorithms for cervical cancer screening in Belgium (1) high-risk human papillomavirus (HR-HPV) primary screening and (2) HR-HPV and liquid-based cytology (LBC) co-testing. METHODS: A decision tree was adapted from published work and parameterised using HORIZON study data and Belgian cost and population data. The theoretical model represents two different screening algorithms for a cohort of 577 846 women aged 25-64 attending routine cervical screening. Scenario analyses were used to explore the impact of including vaccinated women and alternative pricing approaches. Uncertainty analyses were conducted. RESULTS: The cost per woman screened was €113.50 for HR-HPV primary screening and €101.70 for co-testing, representing a total cost of €65 588 573 and €58 775 083, respectively, for the cohort; a 10% difference. For one screening cycle, compared to HR-HPV primary, co-testing resulted in 13 173 more colposcopies, 67 731 more HR-HPV tests and 477 020 more LBC tests. Co-testing identified 2351 more CIN2+ cases per year (27% more than HR-HPV primary) and 1602 more CIN3+ cases (24% more than HR-HPV primary) than HR-HPV primary. CONCLUSION: In Belgium, a co-testing algorithm could increase cervical pre-cancer detection rates compared to HR-HPV primary. Co-testing would cost less than HR-HPV primary if the cost of the HPV test and LBC were cost-neutral compared to the current cost of LBC screening but would cost more if the cost per HPV test and LBC were the same in both co-testing and HR-HPV primary strategies.

18.
PLoS One ; 18(11): e0291143, 2023.
Artigo em Inglês | MEDLINE | ID: mdl-37963144

RESUMO

The article examines the effectiveness of remote monitoring and the evaluation of facts about patients with hematologic malignancies using telemedicine based on SMART technologies. The project was carried out in the Department of Haematooncology of the University Hospital Ostrava. Its objective was to test the efficacy of telemedicine in the treatment of patients with blood cancer. The cost-benefit analysis method was used to evaluate effectiveness, which also confirmed the feasibility of using this method to evaluate the costs and benefits of implementing specific medical projects. The conducted analysis demonstrated the effectiveness of using telemedicine procedures in the treatment of these patients, both in terms of quantifiable and non-quantifiable impacts on the Czech Republic's health system. This was mainly due to a large shortening of the length of the hospitalisation period for patients with problems whose deterioration was discovered by remote monitoring and their treatment could begin promptly. The shortening of the hospitalization period was achieved by around 40%. As a result, the complexity of treatment has been greatly reduced, benefiting both the hospital and, most importantly, the patient. With this prevention, the patient's chances of dying are reduced, as he or she is less likely to develop severe septic diseases. The total average financial savings of the Czech Republic's entire health care system for a patient who does not become septic due to a delayed response to deteriorating health only in hospitalisation, treatment, and medications is approximately USD 2,800.


Assuntos
Telemedicina , Feminino , Humanos , Análise Custo-Benefício , Hospitalização
19.
BMJ Open ; 13(11): e075460, 2023 11 15.
Artigo em Inglês | MEDLINE | ID: mdl-37968005

RESUMO

INTRODUCTION: Breastfeeding has health benefits for infants and mothers, yet the UK has low rates with marked social inequalities. The Assets-based feeding help Before and After birth (ABA) feasibility study demonstrated the acceptability of a proactive, assets-based, woman-centred peer support intervention, inclusive of all feeding types, to mothers, peer supporters and maternity services. The ABA-feed study aims to assess the clinical and cost-effectiveness of the ABA-feed intervention compared with usual care in first-time mothers in a full trial. METHODS AND ANALYSIS: A multicentre randomised controlled trial with economic evaluation to explore clinical and cost-effectiveness, and embedded process evaluation to explore differences in implementation between sites. We aim to recruit 2730 primiparous women, regardless of feeding intention. Women will be recruited at 17 sites from antenatal clinics and various remote methods including social media and invitations from midwives and health visitors. Women will be randomised at a ratio of 1.43:1 to receive either ABA-feed intervention or usual care. A train the trainer model will be used to train local Infant Feeding Coordinators to train existing peer supporters to become 'infant feeding helpers' in the ABA-feed intervention. Infant feeding outcomes will be collected at 3 days, and 8, 16 and 24 weeks postbirth. The primary outcome will be any breastfeeding at 8 weeks postbirth. Secondary outcomes will include breastfeeding initiation, any and exclusive breastfeeding, formula feeding practices, anxiety, social support and healthcare utilisation. All analyses will be based on the intention-to-treat principle. ETHICS AND DISSEMINATION: The study protocol has been approved by the East of Scotland Research Ethics Committee. Trial results will be available through open-access publication in a peer-reviewed journal and presented at relevant meetings and conferences. TRIAL REGISTRATION NUMBER: ISRCTN17395671.


Assuntos
Aleitamento Materno , Mães , Lactente , Feminino , Humanos , Gravidez , Análise Custo-Benefício , Mães/educação , Atenção à Saúde , Aceitação pelo Paciente de Cuidados de Saúde , Ensaios Clínicos Controlados Aleatórios como Assunto , Estudos Multicêntricos como Assunto
20.
Ecotoxicol Environ Saf ; 267: 115643, 2023 Nov 15.
Artigo em Inglês | MEDLINE | ID: mdl-37944462

RESUMO

Biochar is a by-product of thermochemical conversion of biomass or other carbonaceous materials. Recently, it has garnered extensive attention for its high application potential in microbial fuel cell (MFC) systems owing to its high conductivity and low cost. However, the effects of biochar on MFC system performance have not been comprehensively reviewed, thereby necessitating the evaluation of the efficacy of biochar application in MFCs. In this review, biochar characteristics were outlined based on recent publications. Subsequently, various applications of biochar in the MFC systems and their probable processes were summarized. Finally, proposals for future applications of biochar in MFCs were explored along with its perspectives and an environmental evaluation in the context of a circular economy. The purpose of this review is to gain comprehensive insights into the application of biochar in the MFC systems, offering important viewpoints on the effective and steady utilization of biochar in MFCs for practical application.


Assuntos
Fontes de Energia Bioelétrica , Elétrons , Eletrodos , Transporte de Elétrons
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA